Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Responsiveness to QEQ in Men with Erectile Dysfunction Treated with Viagra
NCT00151463Phase 4Completed
- Sponsor
- Viatris
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sildenafil in erectile dysfunction (ED), sponsored by Viatris. Primary endpoint: Treatment response to the Quality of Erection Questionnaire at 10 weeks. Started Jan 2005; status: completed.
02
Drugs
sildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00151463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151463.